 | Lipocine Inc. | |||
| NCM : LPCN || Location: United States | ||||
$4.59+0.15 (+3.38%) |
0.01 M | 4.41 - 4.6 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.109 M |
| March 15, 2024 | 0.124 M |
| Feb. 29, 2024 | 0.111 M |
| Feb. 15, 2024 | 0.131 M |
| Jan. 31, 2024 | 0.144 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.48 | -0.42 | 12.39% |
| 09/30/2023 | -0.61 | -1.27 | -107.52% |
| 06/30/2023 | -0.65 | -0.68 | -4.39% |
| 03/31/2023 | -0.43 | -0.68 | -56.86% |
| 12/31/2022 | -0.52 | -0.51 | 1.96% |
LPCN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 5.348M | Shares Float | 5.158M |
| Short Float | 0.109M | Market Cap | 23.60M |
| Institution ownership | 8.89% | Insider ownership | 3.034% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -3.14 | Forward EPS | -0.57 |